跳至主要内容
临床试验/IRCT20101122005225N8
IRCT20101122005225N8已完成3 期

Evaluation of the efficacy of low-dose naloxone for the prevention of acute remifentanil-induced hyperalgesia in patients undergoing general anesthesia for hysterectomy

Tehran University of Medical Sciences0 个研究点目标入组 75 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
Female

入选标准

  • Female patients aged between 18 to 75 years
  • ASA (American Society of Anesthesiologists) I-II patients
  • Patients scheduled for elective hysterectomy

排除标准

  • Uncontrolled diabetes mellitus
  • Neurologic disorders
  • Psychologic disorders which needs treatment
  • Inflammatory and renal diseases
  • Routine use or taking NSAIDs, opioids or other analgesics 48 hours prior to surgery
  • Allergy or contraindication to anesthetic agents or pain medications, including NSAID’s, acetaminophen and opioids
  • History of any type of chronic pain needs medical or interventional treatments
  • Patient who develop any surgical or anesthetic complication, or need reoperation
  • Patients receiving ketamine, antipsychotic or gabapentinoids

研究者

相似试验